Prs54 - Cost-Effectiveness Analysis of Reslizumab for Patients With Severe Eosinophilic Asthma Inadequately Controlled With High-Dose Inhaled Corticosteroids and Long-Acting B2-Agonists in South Korea

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2448
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Addition of Long-Acting Beta2-Agonists to Inhaled Corticosteroids Versus Same Dose Inhaled Corticosteroids for Chronic Asthma in Adults and Children

Cochrane Database of Systematic Reviews
2010English

Pharmacoeconomic Analysis of Therapy With Reslizumab in Severe Eosinophilic Asthma

Pulmonologiya
PulmonaryRespiratory Medicine
2018English

Addition of Long-Acting Beta-Agonists to Inhaled Corticosteroids for Chronic Asthma in Children

2009English

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients With COPD: Pooled Results of Randomized Placebo-Controlled Trials

Pulmonary Therapy
2016English

Combination Long-Acting Β-Agonists and Inhaled Corticosteroids Compared With Long-Acting Β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Prs34 - Cost and Drug Utilization Trends in Inhaled Corticosteroids/Long-Acting Beta Agonists (Ics/Laba) Fixed-Dose Combinations in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Reslizumab: Add-On Therapy for Severe Eosinophilic Asthma

Prescriber
Pharmacology
2017English

Comparison of High-Dose Inhaled Flunisolide to Systemic Corticosteroids in Severe Adult Asthma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy